Literature DB >> 8795599

Experimental Campylobacter jejuni infection in the chicken: an animal model of axonal Guillain-Barré syndrome.

C Y Li1, P Xue, W Q Tian, R C Liu, C Yang.   

Abstract

OBJECTIVE: To develop and characterise an animal model of paralytic neuropathy after Campylobacter jejuni infection. Campylobacter infection precedes development of many cases of Guillain-Barré syndrome and is particularly associated with cases having prominent axonal degeneration. Understanding the pathogenesis of Guillain-Barré syndrome after C jejuni infection has been slowed by the lack of animal models.
METHODS: A spontaneous paralytic neuropathy is described that developed in chickens from the farms of four patients with Guillain-Barré syndrome. The production of paralytic neuropathy in chickens experimentally fed Campylobacter jejuni isolated from one of these patients is reported. The sciatic nerves of the spontaneously paralysed chickens were examined pathologically in teased fibres, in plastic embedded sections, and by electron microscopy. Two large groups of chickens were then fed cultures of a C jejuni (Penner type O:19) isolated from one of these patients.
RESULTS: The chickens with spontaneous paralysis had pathologically noninflammatory neuropathy. Pathology in the sciatic nerves ranged from no detectable changes to severe Wallerian-like degeneration. In the experimentally inoculated groups, an average of 33% of the chickens became paralysed. The median time after inoculation to paralysis was 12 days. The lesions found in the first few days of paralysis included nodal lengthening and paranodal demyelination. In those animals that survived for several days after onset of weakness, the pathology was dominated by extensive Wallerian-like degeneration. Animals that survived for weeks with no clinically apparent neuropathy had paranodal remyelination in some teased nerve fibres, reflecting earlier paranodal demyelination.
CONCLUSION: Experimental inoculation with C jejuni may provide a new model for understanding some forms of Guillain-Barré syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8795599      PMCID: PMC486551          DOI: 10.1136/jnnp.61.3.279

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  20 in total

1.  Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.

Authors:  N Yuki; H Yoshino; S Sato; K Shinozawa; T Miyatake
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

2.  Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome.

Authors:  N Yuki; S Sato; S Fujimoto; S Yamada; Y Tsujino; A Kinoshita; T Itoh
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

3.  Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome.

Authors:  S Fujimoto; N Yuki; T Itoh; K Amako
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

4.  The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.

Authors:  A K Asbury; B G Arnason; R D Adams
Journal:  Medicine (Baltimore)       Date:  1969-05       Impact factor: 1.889

5.  Is there an axonal variety of GBS?

Authors:  P J Dyck
Journal:  Neurology       Date:  1993-07       Impact factor: 9.910

6.  Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.

Authors:  N Yuki; H Yoshino; S Sato; T Miyatake
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

7.  Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China.

Authors:  G M McKhann; D R Cornblath; J W Griffin; T W Ho; C Y Li; Z Jiang; H S Wu; G Zhaori; Y Liu; L P Jou
Journal:  Ann Neurol       Date:  1993-04       Impact factor: 10.422

8.  An acute axonal form of Guillain-Barré polyneuropathy.

Authors:  T E Feasby; J J Gilbert; W F Brown; C F Bolton; A F Hahn; W F Koopman; D W Zochodne
Journal:  Brain       Date:  1986-12       Impact factor: 13.501

9.  Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome.

Authors:  J W Griffin; C Y Li; C Macko; T W Ho; S T Hsieh; P Xue; F A Wang; D R Cornblath; G M McKhann; A K Asbury
Journal:  J Neurocytol       Date:  1996-01

10.  A prospective study of acute idiopathic neuropathy. II. Antecedent events.

Authors:  J B Winer; R A Hughes; M J Anderson; D M Jones; H Kangro; R P Watkins
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

View more
  8 in total

1.  Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside.

Authors:  Seigo Usuki; Stuart A Thompson; Michael H Rivner; Kyoji Taguchi; Keiko Shibata; Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2006-02-01       Impact factor: 4.164

2.  Epidemiology of peripheral neuropathy.

Authors:  C N Martyn; R A Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

3.  Immunopathology and Th1/Th2 immune response of Campylobacter jejuni-induced paralysis resembling Guillain-Barré syndrome in chicken.

Authors:  Kishan K Nyati; Kashi N Prasad; Nagendra K Kharwar; Priyanka Soni; Nuzhat Husain; Vinita Agrawal; Arun K Jain
Journal:  Med Microbiol Immunol       Date:  2011-11-19       Impact factor: 3.402

4.  Host factors determine anti-GM1 response following oral challenge of chickens with Guillain-Barré syndrome derived Campylobacter jejuni strain GB11.

Authors:  C Wim Ang; Jeroen R Dijkstra; Marcel A de Klerk; Hubert Ph Endtz; Pieter A van Doorn; Bart C Jacobs; Suzan H M Jeurissen; Jaap A Wagenaar
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

5.  Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid a antibody in campylobacteriosis.

Authors:  Seigo Usuki; Yoshihiko Nakatani; Kyoji Taguchi; Tetsuhiro Fujita; Shinya Tanabe; Iku Ustunomiya; Yihua Gu; Shaun A Cawthraw; Diane G Newell; Mohanasundari Pajaniappan; Stuart A Thompson; Toshio Ariga; Robert K Yu
Journal:  J Neurosci Res       Date:  2008-11-15       Impact factor: 4.164

Review 6.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

7.  Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10-/- BALB/c Mice Infected with a Guillain-Barré Syndrome-associated Campylobacter jejuni Strain.

Authors:  Jean M Brudvig; Matthew M Cluett; Elizabeth U Gensterblum-Miller; James Chen; Julia A Bell; Linda S Mansfield
Journal:  Comp Med       Date:  2022-03-10       Impact factor: 1.565

Review 8.  Role of Campylobacter jejuni infection in the pathogenesis of Guillain-Barré syndrome: an update.

Authors:  Kishan Kumar Nyati; Roopanshi Nyati
Journal:  Biomed Res Int       Date:  2013-08-13       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.